Antibodies against deamidated gliadin as new and accurate biomarkers of childhood coeliac disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 49, Issue 1, 2009, Pages 52-58

  Prause, Christian ^a   Ritter, Maria ^a   Probst, Christian ^b   Daehnrich, Cornelia ^b   Schlumberger, Wolfgang ^b   Komorowski, Lars ^b   Lieske, Ruediger ^c   Richter, Thomas ^d   Hauer, Almuthe C ^e   Stern, Martin ^f   Uhlig, Holm H ^a   Laass, Martin W ^g   Zimmer, Klaus Peter ^h   Mothes, Thomas ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b Institute of Experimental Immunology   (Germany)

^c Division Berlin Chemie AG   (Germany)

^d Municipal Children's Hospital Sankt Georg   (Germany)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^h UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Antibodies; Coeliac disease; Deamidated gliadin; Diagnostic accuracy; Tissue transglutaminase

Indexed keywords

BIOLOGICAL MARKER; GLIADIN 1 ANTIBODY; GLIADIN 2 ANTIBODY; GLIADIN ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR GLI2; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

AMIDES; AREA UNDER CURVE; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELIAC DISEASE; CHILD; FEMALE; GLIADIN; HUMANS; MALE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 66749090147     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318195dae3     Document Type: Article

References (30)

1. Green PHR, Cellier C. Celiac disease. N Engl J Med 2007; 357:1731-43.
2. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ("celiac sprue"). Gastroenterology 1992;102:330-54.
3. Collin P, Kaukinen K, Vogelsang H, et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol 2005;17:85-91.
4. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797-801.
5. Osman AA, Richter T, Stern M, et al. Production of recombinant human tissue transglutaminase using baculovirus expression system and its application for serologic diagnosis of coeliac disease. Eur J Gastroenterol Hepatol 2002;14:1217-23.
6. Hill ID. What are the sensitivity and specificity of serologic tests for celiac disease. Do sensitivity and specificity vary in different populations. Gastroenterology 2005;128 (Suppl 1): S25-32.
7. Rostom A, Dube C, Cranney A, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenter ology 2005;128 (Suppl 1): S38-46.
8. van Meensel B, Hiele M, Hoffman I, et al. Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease. Clin Chem 2004;50:2125-35.
9. Osman AA, Günnel T, Dietl A, et al. B cell epitopes of gliadin. Clin Exp Immunol 2000;121:248-54.
10. Aleanzi M, Demonte AM, Esper C, et al. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem 2001;47:2023-8.
11. Schwertz E, Kahlenberg F, Sack U, et al. Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin Chem 2004;50:2370-5.
12. Mothes T. Deamidated gliadin peptides as targets for celiac diseasespecific antibodies. Adv Clin Chem 2007;44:35-63.
13. Prince HE. Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides. Clin Vaccine Immunol 2006;13:150-1.
14. Sugai E, Vazquez H, Nachman F, et al. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease. Clin Gastroenterol Hepatol 2006;4:1112-7.
15. Agardh D. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease. Clin Gastroenterol Hepatol 2007;5: 1276-81.
16. Ankelo M, Kleimola V, Simell S, et al. Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease. Clin Exp Immunol 2007;150:285-93.
17. Kaukinen K, Collin P, Laurila K, et al. Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit. Scand J Gastroenterol 2007;19:1-6.
18. Liu E, Li M, Emery L, et al. Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease. J Pediatr Gastroenterol Nutr 2007;45:293-300.
19. Niveloni S, Sugai S, Cabanne A, et al. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease. Clin Chem 2007;53:2186-92.
20. Villalta D, Alessio MG, Tampoia M, et al. Testing for IgG class antibodies in celiac disease patients with selective IgA deficiency. A comparison of the diagnostic accuracy of 9 IgG anti-tissue transglutaminase, 1 IgG anti-Gliadin and 1 IgG antideaminated gliadin peptide antibody assays. Clin Chim Acta 2007;382:95-9.
21. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185-94.
22. Walker-Smith JA, Guandalini S, Schmitz J, et al. Revised criteria for diagnosis of coeliac disease: report of Working Group of European Society of Pediatric Gastroenterology and Nutrition (ESPGAN). Arch Dis Child 1990;65:909-11.
23. Carroccio A, Iacono G, Montalto G, et al. Immunologic and absorptive tests in celiac disease: can they replace intestinal biopsies. Scand J Gastroenterol 1993;28:673-6.
24. Scoglio R, Di Pasquale G, Pagano G, et al. Is intestinal biopsy always needed for diagnosis of celiac disease. Am J Gastroenterol 2003;98:1325-31.
25. Barker CC, Mitton C, Jevon G, et al. Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations. Pediatrics 2005;115:1341-6.
26. Hill PG, Holmes GKT. Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther 2008;27: 572-7.
27. Collin P, Kaukinen K, Valimaki M, et al. Endocrinological disorders and celiac disease. Endocr Rev 2002;23:464-83.
28. Matysiak-Budnik T, Malamut G, Patey-Mariaud de Serre N, et al. Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet. Gut 2007;56:1379-86.
29. Simell S, Hoppu S, Hekkala A, et al. Fate of five celiac diseaseassociated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study. Am J Gastroenterol 2007;102:2026-35.
30. Collin P, Wahab PJ, Murray JA. Intraepithelial lymphocytes and coeliac disease. Best Pract Res Clin Gastroenterol 2005;19:341-50.